As shown in Table 2, compared to those with non-severe COVID-19, patients with severe COVID-19 had significantly higher circulating levels of neutrophil-to-lymphocyte ratio, C-reactive protein, procalcitonin, D-dimer, IL-6 and IL-10 both in MAFLD and in non-MAFLD patients. This evidence concerns the gene IL6 and COVID-19.